ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 49 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $7,489,000 | +68.1% | 666,891 | 0.0% | 0.02% | +75.0% |
| Q4 2017 | $4,455,000 | -18.4% | 666,891 | 0.0% | 0.01% | -25.0% |
| Q3 2017 | $5,462,000 | +61.4% | 666,891 | -11.5% | 0.02% | +60.0% |
| Q2 2017 | $3,384,000 | -18.5% | 753,741 | 0.0% | 0.01% | -16.7% |
| Q1 2017 | $4,154,000 | +36.1% | 753,741 | 0.0% | 0.01% | +33.3% |
| Q4 2016 | $3,053,000 | -42.5% | 753,741 | +0.0% | 0.01% | -43.8% |
| Q3 2016 | $5,314,000 | -13.5% | 753,740 | 0.0% | 0.02% | -20.0% |
| Q2 2016 | $6,143,000 | +0.2% | 753,740 | 0.0% | 0.02% | +5.3% |
| Q1 2016 | $6,128,000 | -32.6% | 753,740 | 0.0% | 0.02% | -32.1% |
| Q4 2015 | $9,090,000 | +774.0% | 753,740 | +767.9% | 0.03% | +600.0% |
| Q3 2015 | $1,040,000 | -34.7% | 86,849 | 0.0% | 0.00% | -20.0% |
| Q2 2015 | $1,592,000 | – | 86,849 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $2,341,000 | 3.33% |
| Matrix Capital Management Company, LP | 38,974,185 | $66,256,000 | 1.50% |
| NEA Management Company, LLC | 17,082,612 | $29,040,000 | 1.49% |
| Endurant Capital Management LP | 1,824,065 | $3,101,000 | 1.09% |
| Long Focus Capital Management, LLC | 4,679,491 | $7,955,000 | 0.83% |
| Key Client Fiduciary Advisors, LLC | 416,166 | $707,000 | 0.69% |
| PFM Health Sciences, LP | 9,109,780 | $15,487,000 | 0.59% |
| ACT CAPITAL MANAGEMENT, LLC | 90,000 | $153,000 | 0.21% |
| DAFNA Capital Management LLC | 351,064 | $597,000 | 0.16% |
| Rock Springs Capital Management LP | 2,357,544 | $4,008,000 | 0.12% |